← back to search

Ning Li

The First Affiliated Hospital, Sun Yat-sen University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA modifications and cancer, Circular RNAs in diseases, MicroRNA in disease regulation, and Cancer-related molecular mechanisms research.
h-index
33
citations
7,254
works
266
NIH funding
primary concept
Medicine
email

Recent publications

Feasibility of using Simple Diet Self-Assessment Tool (SDSAT) to explore patterns of dietary intake for patients undergoing chemotherapy
Nutrition Journal 2025cited by 0position: middledoi
Integrated molecular characterization of sarcomatoid hepatocellular carcinoma
Clinical and Molecular Hepatology 2024cited by 8position: middledoi
Effects of TACE combined with sorafenib on survival of patients with hepatocellular carcinoma based on ALBI grades and tumor load layers And Establishment of prognosis prediction model
Research Square 2022cited by 0position: middledoi
Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer
Aging 2021cited by 91position: middledoi
Clinical significance of novel identified high‐frequency tumor‐specific peptides associated signature in predicting disease status of gastric cancer patients
BioFactors 2021cited by 1position: middledoi
Matrine promotes hepatic oval cells differentiation into hepatocytes and alleviates liver injury by suppression of Notch signalling pathway
Life Sciences 2020cited by 18position: middledoi
Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A
Bioscience Reports 2020cited by 8position: middledoi
NUCKS1 Acts As A Promising Novel Bio-Marker in The Prognosis of Patients with Hepatocellular Carcinoma
Research Square 2020cited by 5position: middledoi
HTATIP2 Represents an Innovative Bio-marker in Hepatocellular Carcinoma Detection
Research Square 2020cited by 0position: middledoi
Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer
International Journal of Oncology 2018cited by 82position: firstdoi
Prediction of Clinical Deterioration in Hospitalized Adult Patients with Hematologic Malignancies Using a Neural Network Model
PLoS ONE 2016cited by 60position: middledoi
CXCR3 Ligands Are Associated with the Continuum of Diffuse Alveolar Damage to Chronic Lung Allograft Dysfunction
American Journal of Respiratory and Critical Care Medicine 2013cited by 61position: middledoi
Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial
OncoTargets and Therapy 2013cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fei Yin · Hebei Medical University4 papers (2020–2022)Jianfei Shi · Hebei Medical University4 papers (2020–2022)Man Zhao · Hebei Medical University4 papers (2020–2022)Xin Han · Hebei Medical University3 papers (2020–2022)Lili Mi · Hebei Medical University3 papers (2020–2022)Xianfeng Zhang · Sun Yat-sen University Cancer Center2 papers (2020–2020)Xiaoling Duan · Hebei Medical University2 papers (2020–2020)Xianjun Zhang · Wenzhou Medical University2 papers (2020–2020) · 2 papers (2020–2020)Guangjie Han · Hebei Medical University2 papers (2020–2020)Cuizhen Li · Hebei Medical University2 papers (2020–2021)Xinguo Li · Shandong University2 papers (2020–2020)Guang Li · Huazhong University of Science and Technology1 papers (2020–2020)Quan Zhang · Sun Yat-sen University1 papers (2021–2021)Bo Wang · Wuhan University of Technology1 papers (2024–2024)Jinfeng Liu · Zhongshan People's Hospital1 papers (2025–2025)Bo Chen · Wenzhou Medical University1 papers (2013–2013)Xi Zhang · Nanjing Agricultural University1 papers (2025–2025)Wen Zhang · Jiangsu University1 papers (2018–2018)Xia Li · Yale Cancer Center1 papers (2013–2013)